![Teva Pharmaceutical: Shares rise after FDA approves new migraine drug | Business News,The Indian Express Teva Pharmaceutical: Shares rise after FDA approves new migraine drug | Business News,The Indian Express](https://images.indianexpress.com/2017/07/medicines-l.jpg?w=389)
Teva Pharmaceutical: Shares rise after FDA approves new migraine drug | Business News,The Indian Express
![Teva's pursuit of J&J boosted by FDA acceptance of filing for approval of long-acting schizophrenia drug | Fierce Pharma Teva's pursuit of J&J boosted by FDA acceptance of filing for approval of long-acting schizophrenia drug | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1631008555/K%C3%A5re_Schultz.jpg/K%C3%A5re_Schultz.jpg?VersionId=s_4t9O_vhJMy8UzGnAAupmDB6ZEtTLiG)
Teva's pursuit of J&J boosted by FDA acceptance of filing for approval of long-acting schizophrenia drug | Fierce Pharma
![Teva's ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment - Basel St 5, Petah Tikva, Israel Teva's ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment - Basel St 5, Petah Tikva, Israel](https://img.medicalexpo.com/images_me/projects/images-og/teva-s-proair-digihaler-fda-approved-to-monitor-asthma-copd-treatment-26785-13464157.jpg)
Teva's ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment - Basel St 5, Petah Tikva, Israel
![ADDING MULTIMEDIA Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ (albuterol sulfate 117 mcg) Inhalation Powder | Business Wire ADDING MULTIMEDIA Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ (albuterol sulfate 117 mcg) Inhalation Powder | Business Wire](https://mms.businesswire.com/media/20181221005554/en/697186/4/ProAir+Digihaler.jpg)
ADDING MULTIMEDIA Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ (albuterol sulfate 117 mcg) Inhalation Powder | Business Wire
![TEVA PHARMACEUTICAL INDUSTRIES LTD: Teva Announces FDA Approval of AirDuo® Digihaler™ (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder | FDA Health News TEVA PHARMACEUTICAL INDUSTRIES LTD: Teva Announces FDA Approval of AirDuo® Digihaler™ (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder | FDA Health News](https://s3.amazonaws.com/jnswire/jns-media/03/5f/1502281/Digihaler.jpg)
TEVA PHARMACEUTICAL INDUSTRIES LTD: Teva Announces FDA Approval of AirDuo® Digihaler™ (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder | FDA Health News
![FDA declines to approve Teva-MedinCell's risperidone injection for treating schizophrenia | Seeking Alpha FDA declines to approve Teva-MedinCell's risperidone injection for treating schizophrenia | Seeking Alpha](https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1320998287/image_1320998287.jpg?io=getty-c-crop-4-3)